A000230 logo

Ildong Holdings Co., Ltd. Stock Price

KOSE:A000230 Community·₩113.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A000230 Share Price Performance

₩0
-6140.00 (-100.00%)
₩0
-6140.00 (-100.00%)
Price ₩0

A000230 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Fair value with mediocre balance sheet.

2 Risks
1 Reward

Ildong Holdings Co., Ltd. Key Details

₩590.9b

Revenue

₩366.0b

Cost of Revenue

₩224.9b

Gross Profit

₩216.3b

Other Expenses

₩8.6b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
763.00
38.06%
1.46%
55.2%
View Full Analysis

About A000230

Founded
1941
Employees
72
CEO
Woongseop Yoon
WebsiteView website
www.ildongholdings.co.kr

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online; and manufactures original and generic prescription drugs. Further, it offers probiotics; pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions; and engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is headquartered in Seoul, South Korea.

Recent A000230 News & Updates

Recent updates

No updates